Back to Top Skip to main content

Policies

Content for Policies

If you're having trouble finding what you're looking for, consider using fewer words in your search criteria. Results are limited to content that matches all terms in the search field.

We found - potentially matching ""

Specify Date Range (Optional):
Select Content Types (Optional):
Current Filters. Click a Filter to Remove It
Date Range:

DHA TM 4165.01, Volume 4: Defense Medical Logistics Standard Support – Facilities Management (DMLSS-FM): Facility Systems Inventory (FSI) Module

Policy

This Defense Health Agency-Technical Manual (DHA-TM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the Defense Health Agency’s (DHA) procedures for managing data in the Military Health System’s (MHS) Computer Aided Facility Management/Computerized Maintenance Management System (CAFM/CMMS) of record, DMLSS-FM.

  • Identification #: 4165.01, Volume 4
  • Date: 9/6/2018
  • Type: DHA Technical Manual
  • Topics: N/A

2019 Monthly Premium Rates for TRS, TRR, and TYA

Policy

Policy Memorandum to Establish 2019 Monthly Premium Rates for TRICARE Reserve Select, TRICARE Retired Reserve, and TRICARE Young Adult

DHA PI 5025.01: DHA Publication System

Policy

DHA Procedural Instruction 5025.01 establishes the DHA Publication System and provides guidance, assigns responsibilities, and sets procedures for the development, coordination, approval, publication, and review of Defense Health Agency (DHA) publications.

  • Identification #: DHA PI 5025.01
  • Date: 8/24/2018
  • Type: DHA Procedural Instruction
  • Topics: Business Support

DODI 6000.18 Medical Modeling & Simulation Requirements Management

Policy

Purpose: In accordance with the authority in DoD Directive (DoDD) 5124.02, this issuance: • Establishes policy and assigns responsibilities to form and maintain a DoD capability that supports a full range of medical modeling and simulation (MM&S) for planning, decision-making, and education and training programs through Military Health System (MHS) requirement development and approval to achieve MHS standardized MM&S solution sets. • Establishes the Defense Medical Modeling and Simulation Office (DMMSO). • Develop a Medical Modeling and Simulation Requirements Management (MM&SRM) System.

  • Identification #: N/A
  • Date: 8/22/2018
  • Type: Instructions
  • Topics: N/A

DHA PI 6025.08: Pharmacy Enterprise Activity EA

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI): a. Based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (g), establishes the Defense Health Agency’s (DHA) procedures to: (1) Exercise management responsibilities for Pharmacy Shared Service/EA functions in the Military Health System (MHS). This DHA-PI is binding on the MHS and supports the Director’s, DHA, responsibility to develop appropriate management models to maximize efficiencies in the activities carried out by DHA. (2) Recognize the Pharmacy Work Group (PWG) as the operational body to implement pharmacy strategies and programs per the Director’s, DHA, guidance. Also, develop strategic initiatives and business process models to optimize pharmacy operations and programs in accordance with Reference (e). (3) Promulgate guidance, define roles, assign responsibilities, and prescribe procedures for the development, coordination, execution, and implementation of standardized Pharmacy Operations and EA procedures within the MHS and Military Departments (MILDEPs). (4) Execute Pharmacy EA assigned responsibilities and functions, and in accordance with Reference (b), when needed, rely on advice and assistance of governance councils established by the Under Secretary of Defense for Personnel and Readiness and the Assistant Secretary of Defense for Health Affairs (ASD(HA)), including senior representatives of the MILDEPs. (5) Provide DHA combat support agency pharmacy functions, in accordance with Reference (b), specifically involving support for operating forces engaged in planning for, or conducting, military operations, including support during conflict or in the conduct of other military activities related to countering threats to U.S. National Security. The Pharmacy EA innovatively manages and standardizes DoD pharmacy operations in a fiscally responsible manner to optimize readiness, improve health, and lower costs through better care. (6) Support baseline knowledge, skills, and abilities for each wartime pharmacy specialty, addressing gaps between peacetime and deployed operational requirements, in collaboration with the MILDEPs, and military Medical Treatment Facility (MTF) pharmacies. (7) Support programs for skills and knowledge assessments and provide for training/retraining opportunities, as needed, for each wartime pharmacy specialty for military MTF pharmacies. (8) Empower enterprise-level pharmacy clinical communities to define, prioritize, and implement “best-in-class” High Reliability Organization practices to enable readiness through decreasing variation, improving outcomes, and positively impacting healthcare in the MHS. (9) Support the scaling and reconfiguring of pharmacy capabilities required to support the forward operating environment; e.g., hospital ship, combat support hospitals, Expeditionary Medical Support. The Services’ Surgeons General will have deployed medical mission command over health services support of pharmacy resources and capabilities at various levels of command and at diverse locations. b. Transforms varied Tri-Service Pharmacy Operations approaches into a single, integrated DHA Pharmacy Program that standardizes pharmacy shared services and optimizes business processes as directed by the National Defense Authorization Act for Fiscal Year 2017, Section 702 (Reference (c)). c. Drives standardization of institutional and operational commands, sustains and improves medical readiness, creates value within the MHS, and achieves interoperability across platforms to deliver better health care to the warfighter, MHS beneficiaries, and build a medically ready force.

DHA PI 6490.01: BH Treatment and Outcomes Monitoring

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (k): a. Establishes the Defense Health Agency’s (DHA) procedures for the collection and analysis of BH outcome data. b. Addresses how DoD will standardize BH outcome data collection to: assess variations in mental health and substance use care among in-garrison medical treatment facilities (MTFs) and clinics; assess the relationship of treatment protocols and practices to BH outcomes; and identify barriers to provider implementation of evidence-based clinical guidance approved by DoD. c. Designates the Army as the DoD lead Service for maintenance and sustainment of the Behavioral Health Data Portal (BHDP) in specialty care mental health and substance use clinics, referred to collectively as BH clinics, until BHDP functionality can be integrated with GENESIS or another electronic health record (EHR) system managed by DHA. d. Designates DHA Information Operations (J-6) as lead on transitioning BHDP functional requirements related to outcomes monitoring to future EHR data collection platforms and processes.

TRICARE Retail Refund DoD Pricing Agreement

Policy

This agreement satisfies the requirement of TRICARE regulation (32 CFR 199.21(q)(2)(i)) for a manufacturer’s written agreement and for establishing refund procedures (32 CFR 199.21(q)(3)(i)).

  • Identification #: N/A
  • Date: 7/9/2018
  • Type: Guidelines
  • Topics: N/A

Guidance for the 2018-2019 Annual Influenza Immunization Program

Policy

ASD(HA) memo detailing the forthcoming immunization requirements for the 2018-19 influenza season.

CORRIGENDUM FOR “Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline”

Policy

This describes errors made in the original document, and summarizes the corrections made to the recommendations.

UPDATE TO NOTIFICATION OF TEMPORARY CHANGE IN POLIO VACCINATION GUIDANCE FOR UNITED STATES AFRICA COMMAND (USAFRICOM) THEATER

Policy
  • Identification #: N/A
  • Date: 7/1/2018
  • Type: Guidelines
  • Topics: Polio

YELLOW FEVER VACCINATION REQUIREMENTS FOR THE US AFRICA COMMAND (USAFRICOM) THEATER (MODIFICATION 2 - EXCEPTION FOR ASCENSION ISLAND)

Policy
  • Identification #: N/A
  • Date: 7/1/2018
  • Type: Guidelines
  • Topics: Yellow Fever

DoDI 6000.11: PATIENT MOVEMENT

Policy

Establishes policy, assigns responsibilities, and defines roles for implementation of the DoD PM mission.

  • Identification #: DoDI 6000.11: PATIENT MOVEMENT
  • Date: 6/22/2018
  • Type: Instructions
  • Topics: N/A

DHA PI 6025.07: Naloxone in the MTFs

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (h), establishes the Defense Health Agency’s (DHA) procedures for prescribing and dispensing naloxone by pharmacists in MTFs to eligible beneficiaries, upon beneficiary request, or when the pharmacist determines the beneficiary meets the established criteria for being at risk for a life-threatening opiate overdose.

DHA PI 6025.04: Pain Management and Opioid Safety in the MHS

Policy

The purpose of our MHS Pain Management Campaign is to enable Clinical Communities to provide evidence-based pain management guided by clinical practice guidelines (CPGs): effectively treat acute and chronic pain; promote non-pharmacologic treatment; prevent acute pain from becoming chronic; and minimize use of opioids with appropriate prescribing only when indicated. The Pain Management Clinical Support Service achieves these ends through clinical improvements in pain care, clinician and patient education, and research. This Defense Health Agency-Procedural Instruction (DHA-PI) is a dual effort between the Pain Management Clinical Support Service and the Clinical Communities to achieve our stated purpose through implementation of the MHS Stepped Care Model.

DHA PI 6025.06: Standardized Templates for Primary Care Clinical Encounter Documentation

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (d), establishes the Defense Health Agency’s (DHA) procedures for all DoD Medical Treatment Facilities (MTFs) providing healthcare services in the direct care system. In support of direct care system MTFs delivering a standard scope of primary care to all beneficiaries, clinicians will use standardized electronic entry forms for electronic health record systems. This is in compliance with Reference (d). Standardized templates supporting clinical practice guidelines, care pathways, and standardized workflow will be used for documenting all outpatient face-to-face encounters in primary care. Tri-Service Workflow (TSWF) adult and pediatric CORE forms will be used in Armed Forces Health Longitudinal Technology Application (AHLTA), and the equivalent forms within Military Health System (MHS) GENESIS.

  • Identification #: DHA PI 6025.06
  • Date: 5/16/2018
  • Type: DHA Procedural Instruction
  • Topics: N/A
<< < ... 6 7 8 9 10  ... > >> 
Showing results 91 - 105 Page 7 of 73

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing: Download a PDF Reader or learn more about PDFs.